Rational mutational analysis of a multidrug MFS transporter CaMdr1p of Candida albicans by employing a membrane

Khyati Kapoor1, Mohd Rehan, Ajeeta Kaushiki

  • 1School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.

Plos Computational Biology
|December 31, 2009
PubMed

Insights

Identifying critical residues in Candida albicans multidrug transporter CaMdr1p is key to combating azole resistance. Mutating these residues in Saccharomyces cerevisiae increased drug susceptibility, revealing their importance for transporter function.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • CaMdr1p, a multidrug transporter in *Candida albicans*, is implicated in azole resistance.
  • Understanding CaMdr1p structure and function is crucial for developing new antifungal therapies.

Purpose of the Study:

  • To computationally predict functionally critical residues of CaMdr1p.
  • To validate the functional importance of predicted residues through experimental analysis.

Main Methods:

  • Utilized a membrane-based computational approach using Modified Relative Entropy (RE(M)) from Multiple Sequence Alignment (MSA).
  • Performed site-directed mutational analysis on predicted critical residues in a heterologous host (*Saccharomyces cerevisiae*).
  • Assessed drug susceptibility, substrate efflux, protein expression, and surface localization of mutant variants.

Main Results:

  • Mutational analysis of high RE(M) residues in CaMdr1p led to increased drug susceptibility in *S. cerevisiae*.
  • Hypersensitivity was linked to abrogated substrate efflux, not altered protein expression or localization.
  • A 3D model suggested critical residues maintain inter-helical interactions essential for transporter function.

Conclusions:

  • Identified functionally critical residues of CaMdr1p using a computational approach.
  • Experimental validation confirmed the role of these residues in CaMdr1p function and drug efflux.
  • Findings have implications for understanding and targeting multidrug transporters in other membrane protein families.